Uncontrolled blood pressure and treatment of hypertension in older chronic kidney disease patients.
作者信息
Gannon Michael P, Wu Edward, McMahon Gearoid M, Aaron Skye, Bates David W, Waikar Sushrut, Samal Lipika
机构信息
Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Alabama College of Osteopathic Medicine, Dothan, Alabama, USA.
出版信息
J Am Geriatr Soc. 2021 Oct;69(10):2985-2987. doi: 10.1111/jgs.17304. Epub 2021 Jun 5.
Abstract
摘要
相似文献
1
Uncontrolled blood pressure and treatment of hypertension in older chronic kidney disease patients.老年慢性肾脏病患者的血压控制不佳与高血压治疗
J Am Geriatr Soc. 2021 Oct;69(10):2985-2987. doi: 10.1111/jgs.17304. Epub 2021 Jun 5.
2
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.慢性肾脏病中貌似治疗抵抗性高血压的患病率及预后意义：慢性肾功能不全队列研究报告
Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28.
3
Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study.细胞外液量是慢性肾脏病中未控制和耐药性高血压的独立决定因素：一项NephroTest 队列研究。
J Am Heart Assoc. 2018 Oct 2;7(19):e010278. doi: 10.1161/JAHA.118.010278.
4
Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).中国慢性肾脏病成人高血压控制情况：中国慢性肾脏病队列研究（C-STRIDE）的基线结果。
Am J Hypertens. 2018 Mar 10;31(4):486-494. doi: 10.1093/ajh/hpx222.
5
Mechanisms of Antihypertensive Effect of Chlorthalidone in Advanced Chronic Kidney Disease: A Causal Mediation Analysis.氯噻酮在晚期慢性肾脏病中降压作用的机制：因果中介分析。
Clin J Am Soc Nephrol. 2024 Aug 1;19(8):1025-1032. doi: 10.2215/CJN.0000000000000484. Epub 2024 Jun 12.
6
7
Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.澳大利亚昆士兰州非透析慢性肾病高血压患者的血压管理。
BMC Nephrol. 2019 Sep 4;20(1):348. doi: 10.1186/s12882-019-1532-6.
8
Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease.在慢性肾脏病中，血压控制和抗高血压药物处方模式存在相当大的国际差异。
Kidney Int. 2019 Oct;96(4):983-994. doi: 10.1016/j.kint.2019.04.032. Epub 2019 Jul 26.
9
Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5.血压变异性与利尿剂与慢性肾脏病 1-5 期患者心血管事件的关联。
Hypertension. 2021 Mar 3;77(3):948-959. doi: 10.1161/HYPERTENSIONAHA.120.16117. Epub 2021 Jan 11.
10
Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.慢性肾脏病患者强化血压目标的死亡率结果。
Hypertension. 2019 Jun;73(6):1275-1282. doi: 10.1161/HYPERTENSIONAHA.119.12697.
引用本文的文献
1
User Actions within a Clinical Decision Support Alert for the Management of Hypertension in Chronic Kidney Disease.慢性肾脏病高血压管理临床决策支持警报中的用户操作
Appl Clin Inform. 2025 May;16(3):595-603. doi: 10.1055/a-2554-3969. Epub 2025 Mar 17.
2
Trends in Blood Pressure Control in US Adult CKD Patients from 1999 to 2018.1999年至2018年美国成年慢性肾脏病患者的血压控制趋势
Int J Med Sci. 2025 Jan 13;22(3):696-707. doi: 10.7150/ijms.103107. eCollection 2025.
3
Refining Clinical Phenotypes to Improve Clinical Decision Support and Reduce Alert Fatigue: A Feasibility Study.精炼临床表型以改善临床决策支持和减少警报疲劳：一项可行性研究。
Appl Clin Inform. 2023 May;14(3):528-537. doi: 10.1055/s-0043-1768994. Epub 2023 Jul 12.
本文引用的文献
1
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师助理学会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药剂师协会/美国血液学会/美国预防心脏病学会/美国国家医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2018 Oct 23;138(17):e426-e483. doi: 10.1161/CIR.0000000000000597.
2
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南：欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会：欧洲心脏病学会动脉高血压管理特别工作组和欧洲高血压学会。
J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.
3
Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians.《成年人 60 岁及以上患者高血压治疗：血压目标值更高或更低的药物治疗：美国医师学会和美国家庭医生学会临床实践指南》。
Ann Intern Med. 2017 Mar 21;166(6):430-437. doi: 10.7326/M16-1785. Epub 2017 Jan 17.
4
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.强化与标准血压控制对≥75岁成年人心血管疾病结局的影响：一项随机临床试验。
JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.
5
A new equation to estimate glomerular filtration rate.一种估算肾小球滤过率的新公式。
Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.
6
Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.非裔美国人肾病与高血压研究（AASK）试验中的心血管结局
Am J Kidney Dis. 2006 Nov;48(5):739-51. doi: 10.1053/j.ajkd.2006.08.004.
7
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.特定年龄的正常血压与血管性死亡率的相关性：对61项前瞻性研究中100万成年人个体数据的荟萃分析
Lancet. 2002 Dec 14;360(9349):1903-13. doi: 10.1016/s0140-6736(02)11911-8.
Zotero 插件